These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 12728856)
21. Maraviroc--new HIV drug. Emerging options need to be used wisely. Vázquez E Posit Aware; 2007; 18(4):18-9. PubMed ID: 17682275 [No Abstract] [Full Text] [Related]
22. FUZEON (enfuvirtide, T-20). Breaking barriers or breaking the bank? Sharp M; Camp R GMHC Treat Issues; 2003 Mar; 17(3):7-8. PubMed ID: 12728858 [No Abstract] [Full Text] [Related]
24. Fuzeon combination highly effective. AIDS Patient Care STDS; 2006 Dec; 20(12):888. PubMed ID: 17219619 [No Abstract] [Full Text] [Related]
25. FDA notifications. FDA approves Fuzeon, the first fusion inhibitor. AIDS Alert; 2003 Jun; 18(6):78-9. PubMed ID: 12866478 [No Abstract] [Full Text] [Related]
26. T-20 continues to look promising. AIDS Patient Care STDS; 1999 Dec; 13(12):753. PubMed ID: 10743540 [No Abstract] [Full Text] [Related]
27. T-1249 development suspended. Huff B GMHC Treat Issues; 2003 Dec; 17(12):6. PubMed ID: 15011643 [No Abstract] [Full Text] [Related]
29. Emerging drugs in the fight against HIV disease. Rosenthal E HRSA Careaction; 2003 Feb; ():1-8. PubMed ID: 12739497 [No Abstract] [Full Text] [Related]